Management of in-stent restenosis in the superficial femoral artery

Journal of Cardiovascular Surgery

Volumn 57, Issue 2, 2016, Pages 248-256

  Van Den Berg, Jos C ^a  

^a REGIONAL HOSPITAL OF LUGANO   (Switzerland)

Author keywords

Coronary restenosis; Femoral artery; Stents

Indexed keywords

BIGLYCAN; DECORIN; ELASTIN; GLYCOPROTEIN; HYALURONIC ACID; PACLITAXEL; PROTEOGLYCAN; VERSICAN;

ARTICLE; ATHERECTOMY; BLOOD VESSEL PERMEABILITY; CELL DIVISION; CELL MIGRATION; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; ENDOPROSTHESIS; FEMOROPOPLITEAL BYPASS; HUMAN; IN-STENT RESTENOSIS; LASER SURGERY; LIPID METABOLISM; MULTICENTER STUDY (TOPIC); PACLITAXEL ELUTING CORONARY STENT; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUPERFICIAL FEMORAL ARTERY; TREATMENT OUTCOME; CRYOTHERAPY; DISEASE MANAGEMENT; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; LOW LEVEL LASER THERAPY; PERIPHERAL ARTERIAL DISEASE; PROCEDURES; REOPERATION; STENT;

ANGIOPLASTY, BALLOON; CRYOTHERAPY; DISEASE MANAGEMENT; FEMORAL ARTERY; GRAFT OCCLUSION, VASCULAR; HUMANS; LASER THERAPY; PERIPHERAL ARTERIAL DISEASE; REOPERATION; STENTS;

EID: 84977465756     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Diehm NA, Hoppe H, Do DD. Drug eluting balloons. Tech Vasc Interv Radiol 2010;13:59-63.
2. Laird JR, Katzen BT, Scheinert D, Lammer J, Carpenter J, Buchbinder M, et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: Twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv 2010;3:267-76.
3. Schillinger M, Sabeti S, Dick P, Amighi J, Mlekusch W, Schlager O, et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 2007;115:2745-9.
4. Siablis D, Karnabatidis D, Katsanos K, Diamantopoulos A, Spiliopoulos S, Kagadis GC, et al. Infrapopliteal application of sirolimuseluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol 2009;20:1141-50.
5. Sullivan TM, Ainsworth SD, Langan EM, Taylor S, Snyder B, Cull D, et al. Effect of endovascular stent strut geometry on vascular injury, myointimal hyperplasia, and restenosis. J Vasc Surg 2002;36:143-9.
6. Carter AJ, Laird JR, Farb A, Kufs W, Wortham DC, Virmani R. Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. J Am Coll Cardiol 1994;24:1398-405.
7. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999;99:44-52.
8. Farb A, Virmani R, Atkinson JB, Kolodgie FD. Plaque morphology and pathologic changes in arteries from patients dying after coronary balloon angioplasty. J Am Coll Cardiol 1990;16:1421-9.
9. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med 2009;14:73- 89.
10. Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphological predictors of restenosis after coronary stenting in humans. Circulation 2002;105:2974-80.
11. Inoue S, Koyama H, Miyata T, Shigematsu H. Pathogenetic heterogeneity of in-stent lesion formation in human peripheral arterial disease. J Vasc Surg 2002;35:672-8.
12. Iida O, Uematsu M, Soga Y, Hirano K, Suzuki K, Yokoi H, et al. Timing of the restenosis following nitinol stenting in the superficial femoral artery and the factors associated with early and late restenoses. Catheter Cardiovasc Interv 2011;78:611-7.
13. Osherov AB, Gotha L, Cheema AN, Qiang B, Strauss BH. Proteins mediating collagen biosynthesis and accumulation in arterial repair: novel targets for anti-restenosis therapy. Cardiovasc Res 2011;91:16- 26.
14. Farb A, Kolodgie FD, Hwang JY, Burke AP, Tefera K, Weber DK, et al. Extracellular matrix changes in stented human coronary arteries. Circulation 2004;110:940-7.
15. Tosaka A, Soga Y, Iida O, Ishihara T, Hirano K, Suzuki K, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012;59:16-23.
16. Dick P, Sabeti S, Mlekusch W, Schlager O, Amighi J, Haumer M, et al. Conventional balloon angioplasty versus peripheral cutting balloon angioplasty for treatment of femoropopliteal artery in-stent restenosis: initial experience. Radiology 2008;248:297-302.
17. Armstrong EJ, Singh S, Singh GD, Yeo KK, Ludder S, Westin G, et al. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention. Catheter Cardiovasc Interv 2013;82:1168-74.
18. Karthik S, Tuite DJ, Nicholson AA, Patel JV, Shaw DR, McPherson SJ, et al. Cryoplasty for arterial restenosis. Eur J Vasc Endovasc Surg 2007;33:40-3.
19. Shin SH, Baril DT, Chaer RA, Makaroun MS, Marone LK. Cryoplasty offers no advantage over standard balloon angioplasty for the treatment of in-stent stenosis. Vascular 2013 Mar 14 [Epub ahead of print].
20. Zeller T, Dake MD, Tepe G, Brechtel K, Noory E, Beschorner U, et al. Treatment of femoropopliteal in-stent restenosis with paclitaxeleluting stents. JACC Cardiovasc Interv 2013;6:274-81.
21. Leopardi M, Houbballah R, Becquemin JP. Effectiveness of Zilver PTX eluting stent in TASC C/D lesions and restenosis. J Cardiovasc Surg (Torino) 2014;55:229-34.
22. Armstrong EJ, Thiruvoipati T, Tanganyika K, Singh GD, Laird JR. Laser Atherectomy for Treatment of Femoropopliteal In-Stent Restenosis. J Endovasc Ther 2015;22:506-13.
23. Laird JR Jr., Yeo KK, Rocha-Singh K, Das T, Joye J, Dippel E, et al. Excimer laser with adjunctive balloon angioplasty and heparin-coated self-expanding stent grafts for the treatment of femoropopliteal artery in-stent restenosis: Twelve-month results from the SALVAGE study. Catheter Cardiovasc Interv 2012;80:852-9.
24. Bosiers M, Deloose K, Callaert J, Verbist J, Hendriks J, Lauwers P, et al. Superiority of stent-grafts for in-stent restenosis in the superficial femoral artery: Twelve-month results from a multicenter randomized trial. J Endovasc Ther 2015;22:1-10.
25. Stabile E, Virga V, Salemme L, Cioppa A, Ambrosini V, Sorropago G, et al. Drug-eluting balloon for treatment of superficial femoral artery in-stent restenosis. J Am Coll Cardiol 2012;60:1739-42.
26. Virga V, Stabile E, Biamino G, Salemme L, Cioppa A, Giugliano G, et al. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up. JACC Cardiovasc Interv 2014;7:411-5.
27. Liistro F, Angioli P, Porto I, Ricci L, Ducci K, Grotti S, et al. Paclitaxel- eluting balloon vs. standard angioplasty to reduce recurrent restenosis in diabetic patients with in-stent restenosis of the superficial femoral and proximal popliteal arteries: The DEBATE-ISR study. J Endovasc Ther 2014;21:1-8.
28. Krankenberg H, Tubler T, Ingwersen M, Schluter M, Scheinert D, Blessing E, et al. Drug-coated balloon versus standard balloon for superficial femoral artery in-stent restenosis: The randomized Femoral Artery In-Stent Restenosis (FAIR ) Trial. Circulation 2015;132:2230- 6.
29. Trentmann J, Charalambous N, Djawanscher M, Schafer JP, Jahnke T. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg (Torino) 2010;51:551-60.
30. Zeller T, Rastan A, Sixt S, Schwarzwalder U, Schwarz T, Frank U, et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol 2006;48:1573-8.
31. Shammas NW, Shammas GA, Jerin M. Differences in patient selection and outcomes between SilverHawk atherectomy and laser ablation in the treatment of femoropopliteal in-stent restenosis: a retrospective analysis from a single center. J Endovasc Ther 2013;20:844-52.
32. Schmidt A, Zeller T, Sievert H, Krankenberg H, Torsello G, Stark MA, et al. Photoablation using the turbo-booster and excimer laser for in-stent restenosis treatment: Twelve-month results from the PATENT Study. J Endovasc Ther 2014;21:52-60.
33. Dippel EJ, Makam P, Kovach R, George JC, Patlola R, Metzger DC, et al. Randomized controlled study of excimer laser atherectomy for treatment of femoropopliteal in-stent restenosis: initial results from the EXCITE ISR trial (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis). JACC Cardiovasc Interv 2015;8(1 Pt A):92-101.
34. Van Den Berg, JC, Pedrotti M, Canevascini R, Chimchila CS, Giovannacci L, Rosso R. Endovascular treatment of in-stent restenosis using excimer laser angioplasty and drug eluting balloons. J Cardiovasc Surg (Torino) 2012;53:215-22.
35. Van Den Berg, JC, Pedrotti M, Canevascini R, Chimchila CS, Giovannacci L, Rosso R. In-stent restenosis: mid-term results of debulking using excimer laser and drug-eluting balloons: sustained benefit? J Invasive Cardiol 2014;26:333-7.
36. Gandini R, Del GC, Merolla S, Morosetti D, Pampana E, Simonetti G. Treatment of chronic SFA in-stent occlusion with combined laser atherectomy and drug-eluting balloon angioplasty in patients with critical limb ischemia: a single-center, prospective, randomized study. J Endovasc Ther 2013;20:805-14.
37. Sixt S, Carpio Cancino OG, Treszl A, Beschorner U, Macharzina R, Rastan A, et al. Drug-coated balloon angioplasty after directional atherectomy improves outcome in restenotic femoropopliteal arteries. J Vasc Surg 2013;58:682-6.